Istodax romidepsin: Phase Ib/II data

An open-label, dose-escalation, French Phase Ib/II trial in 35 evaluable patients with PTCL showed that IV Istodax plus CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine and prednisone) le...